Camlin Fine Sciences Limited (CAMLINFINE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Camlin Fine Sciences Limited (CAMLINFINE) has a cash flow conversion efficiency ratio of 0.078x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs671.39 Million ≈ $7.26 Million USD) by net assets (Rs8.60 Billion ≈ $93.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Camlin Fine Sciences Limited (CAMLINFINE) net asset quality to measure how much of total assets are equity-financed.
Camlin Fine Sciences Limited - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Camlin Fine Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CAMLINFINE cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Camlin Fine Sciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Camlin Fine Sciences Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Habco Trans Maritima
JK:HATM
|
0.017x |
|
Western New England Bancorp Inc
NASDAQ:WNEB
|
0.023x |
|
Eco Atlantic Oil & Gas Ltd
V:EOG
|
0.056x |
|
Eaton Vance National Municipal Opportunities Closed Fund
NYSE:EOT
|
0.020x |
|
Twin Disc Incorporated
NASDAQ:TWIN
|
0.028x |
|
Synnex (Thailand) Public Company Limited
BK:SYNEX
|
-0.109x |
|
Clearview Wealth Ltd
AU:CVW
|
-3.782x |
|
Jiangsu Hongde Special Parts Co.Ltd.
SHE:301163
|
0.012x |
Annual Cash Flow Conversion Efficiency for Camlin Fine Sciences Limited (2007–2025)
The table below shows the annual cash flow conversion efficiency of Camlin Fine Sciences Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Camlin Fine Sciences Limited market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs8.75 Billion ≈ $94.60 Million |
Rs267.23 Million ≈ $2.89 Million |
0.031x | -81.16% |
| 2024-03-31 | Rs8.57 Billion ≈ $92.68 Million |
Rs1.39 Billion ≈ $15.03 Million |
0.162x | +162.59% |
| 2023-03-31 | Rs8.24 Billion ≈ $89.12 Million |
Rs508.98 Million ≈ $5.50 Million |
0.062x | -67.51% |
| 2022-03-31 | Rs7.65 Billion ≈ $82.74 Million |
Rs1.45 Billion ≈ $15.73 Million |
0.190x | +15.50% |
| 2021-03-31 | Rs7.13 Billion ≈ $77.12 Million |
Rs1.17 Billion ≈ $12.69 Million |
0.165x | -11.96% |
| 2020-03-31 | Rs4.60 Billion ≈ $49.76 Million |
Rs860.20 Million ≈ $9.30 Million |
0.187x | +994.14% |
| 2019-03-31 | Rs4.30 Billion ≈ $46.53 Million |
Rs-89.97 Million ≈ $-972.97K |
-0.021x | +41.19% |
| 2018-03-31 | Rs4.33 Billion ≈ $46.87 Million |
Rs-154.09 Million ≈ $-1.67 Million |
-0.036x | +5.85% |
| 2017-03-31 | Rs2.30 Billion ≈ $24.89 Million |
Rs-86.93 Million ≈ $-940.15K |
-0.038x | -109.30% |
| 2016-03-31 | Rs1.76 Billion ≈ $19.06 Million |
Rs715.72 Million ≈ $7.74 Million |
0.406x | +18.42% |
| 2015-03-31 | Rs1.35 Billion ≈ $14.59 Million |
Rs462.55 Million ≈ $5.00 Million |
0.343x | +19.66% |
| 2014-03-31 | Rs933.04 Million ≈ $10.09 Million |
Rs267.42 Million ≈ $2.89 Million |
0.287x | -66.30% |
| 2013-03-31 | Rs653.83 Million ≈ $7.07 Million |
Rs556.14 Million ≈ $6.01 Million |
0.851x | +241.22% |
| 2012-03-31 | Rs529.06 Million ≈ $5.72 Million |
Rs-318.65 Million ≈ $-3.45 Million |
-0.602x | -769.37% |
| 2011-03-31 | Rs464.53 Million ≈ $5.02 Million |
Rs41.80 Million ≈ $452.03K |
0.090x | +142.33% |
| 2010-03-31 | Rs291.32 Million ≈ $3.15 Million |
Rs10.82 Million ≈ $116.98K |
0.037x | -77.42% |
| 2009-03-31 | Rs291.41 Million ≈ $3.15 Million |
Rs47.91 Million ≈ $518.17K |
0.164x | +20.49% |
| 2008-03-31 | Rs278.32 Million ≈ $3.01 Million |
Rs37.98 Million ≈ $410.72K |
0.136x | -78.93% |
| 2007-03-31 | Rs199.57 Million ≈ $2.16 Million |
Rs129.28 Million ≈ $1.40 Million |
0.648x | -- |
About Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate… Read more